We are live on ! Find out more
TECH icon

Bio-Techne

332 hedge funds and large institutions have $5.43B invested in Bio-Techne in 2018 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 103 increasing their positions, 110 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

174% more first-time investments, than exits

New positions opened: 63 | Existing positions closed: 23

30% more call options, than puts

Call options by funds: $1.89M | Put options by funds: $1.45M

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

15% more capital invested

Capital invested by funds: $4.72B → $5.43B (+$710M)

12% more funds holding

Funds holding: 297332 (+35)

6% less repeat investments, than reductions

Existing positions increased: 103 | Existing positions reduced: 110

5.21% less ownership

Funds ownership: 388.84%383.63% (-5.2%)

Holders
332
Holders Change
+35
Holders Change %
+11.78%
% of All Funds
7.61%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
63
Increased
103
Reduced
110
Closed
23
Calls
$1.89M
Puts
$1.45M
Net Calls
+$434K
Net Calls Change
+$564K
Name Holding Trade Value Shares
Change
Change in
Stake
SGH
126
Sivik Global Healthcare
Connecticut
$3.02M +$2.83M +80,000 New
RHJA
127
Rice Hall James & Associates
California
$2.9M -$12K -340 -0.4%
UBS Group
128
UBS Group
Switzerland
$2.85M +$1.09M +30,760 +69%
MSA
129
Mason Street Advisors
Wisconsin
$2.84M +$51.7K +1,464 +2%
LIM
130
Leavell Investment Management
Alabama
$2.71M
FNBOO
131
First National Bank of Omaha
Nebraska
$2.71M +$188K +5,320 +5%
Nisa Investment Advisors
132
Nisa Investment Advisors
Missouri
$2.68M
RP
133
Rowlandmiller & Partners
Georgia
$2.68M -$314K -8,900 -11%
Man Group
134
Man Group
United Kingdom
$2.68M +$2.51M +70,928 New
FP
135
Foundry Partners
Minnesota
$2.65M +$32.8K +928 +1%
PA
136
Profund Advisors
Maryland
$2.62M -$70.2K -1,988 -3%
Bank of Montreal
137
Bank of Montreal
Ontario, Canada
$2.61M +$124K +3,512 +5%
CAM
138
ClariVest Asset Management
California
$2.49M +$2.33M +65,900 New
PAM
139
Palisade Asset Management
Minnesota
$2.41M
Federated Hermes
140
Federated Hermes
Pennsylvania
$2.33M +$72.1K +2,040 +3%
Squarepoint
141
Squarepoint
New York
$2.29M +$1.81M +51,308 +554%
FIM
142
Freedom Investment Management
Connecticut
$2.28M +$7.35K +208 +0.3%
T. Rowe Price Associates
143
T. Rowe Price Associates
Maryland
$2.17M +$9.19K +260 +0.5%
RJA
144
Raymond James & Associates
Florida
$2.17M +$24.6K +696 +1%
OPERF
145
Oregon Public Employees Retirement Fund
Oregon
$2.12M +$13.1K +372 +0.7%
RAM
146
Redmond Asset Management
Virginia
$2.09M -$101K -2,868 -5%
OAM
147
Oppenheimer Asset Management
New York
$2.09M +$236K +6,676 +14%
DekaBank Deutsche Girozentrale
148
DekaBank Deutsche Girozentrale
Germany
$2.09M -$465K -13,160 -19%
SOMRS
149
State of Michigan Retirement System
Michigan
$2.07M +$28.3K +800 +1%
VOYA Investment Management
150
VOYA Investment Management
Georgia
$2.02M -$19.1K -540 -1%

TECH Hedge Fund Activity: Q1 2018 in Review

332 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2018, worth a combined $5.43B — up 15% from $4.72B a quarter earlier.

Buyers outnumbered sellers: 63 funds opened new TECH positions and 23 closed out — a net gain of 40 holders — while 103 added to existing stakes and 110 trimmed.

The largest buyer was Massachusetts Financial Services, adding an estimated $53.1M. The largest seller was Select Equity Group, cutting an estimated $96.4M.

  • 332 institutional investors held Bio-Techne (TECH) as of Q1 2018, up from 297 in Q4 2017.
  • Funds reported $5.43B of Bio-Techne stock for Q1 2018, up 15% quarter-over-quarter.
  • 63 funds opened new Bio-Techne positions in Q1 2018 and 23 closed out, a net change of +40 holders.
  • The largest Bio-Techne buyer in Q1 2018 was Massachusetts Financial Services, an estimated $53.1M added.
  • The largest Bio-Techne seller in Q1 2018 was Select Equity Group, an estimated $96.4M sold.

Based on aggregated 13F filings for Q1 2018.